These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
420 related items for PubMed ID: 12005083
21. [Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous stem cell transplantation]. Zikesoá E, Hnátková M, Vacková B, Jedlicková A, Klener P, Trnený M. Cas Lek Cesk; 2006; 145(5):383-6, 388-9. PubMed ID: 16755776 [Abstract] [Full Text] [Related]
22. Ceftazidime versus ceftazidime plus tobramycin in febrile neutropenic children. Jacobs RF, Vats TS, Pappa KA, Chaudhary S, Kletzel M, Becton DL. Infection; 1993; 21(4):223-8. PubMed ID: 8225625 [Abstract] [Full Text] [Related]
24. Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients. Laszlo D, Bacci S, Bosi A, Fanci R, Guidi S, Saccardi R, Vannucchi AM, Rossi Ferrini P. J Chemother; 1997 Apr; 9(2):95-101. PubMed ID: 9176746 [Abstract] [Full Text] [Related]
25. Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer. Riikonen P. Pediatr Infect Dis J; 1991 Dec; 10(12):918-23. PubMed ID: 1766707 [Abstract] [Full Text] [Related]
27. [Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor]. Marie-Cardine A, Schneider P, Blot N, Tron P, Vannier JP. Arch Pediatr; 2003 Apr; 10(4):307-12. PubMed ID: 12818750 [Abstract] [Full Text] [Related]
28. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial. Feld R, DePauw B, Berman S, Keating A, Ho W. J Clin Oncol; 2000 Nov 01; 18(21):3690-8. PubMed ID: 11054442 [Abstract] [Full Text] [Related]
30. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients. Hamidah A, Lim YS, Zulkifli SZ, Zarina AL, Nordiah AJ, Jamal R. Singapore Med J; 2007 Jul 01; 48(7):615-9. PubMed ID: 17609821 [Abstract] [Full Text] [Related]
34. Cefepime monotherapy for treatment of febrile neutropenia in children. Ariffin H, Ai CL, Lee CL, Abdullah WA. J Paediatr Child Health; 2006 Dec 01; 42(12):781-4. PubMed ID: 17096713 [Abstract] [Full Text] [Related]
35. Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer). Biron P, Fuhrmann C, Cure H, Viens P, Lefebvre D, Thyss A, Viot M, Soler-Michel P, Rollin C, Grès JJ. J Antimicrob Chemother; 1998 Oct 01; 42(4):511-8. PubMed ID: 9818751 [Abstract] [Full Text] [Related]
36. Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients. Yamamura D, Gucalp R, Carlisle P, Cimino M, Roberts J, Rotstein C. Antimicrob Agents Chemother; 1997 Aug 01; 41(8):1704-8. PubMed ID: 9257745 [Abstract] [Full Text] [Related]
37. An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group. Höffken G, Pasold R, Pflüger KH, Finke J, Fauser AA, Szelenyi H, Wagner J. J Antimicrob Chemother; 1999 Sep 01; 44(3):367-76. PubMed ID: 10511404 [Abstract] [Full Text] [Related]
39. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem. Freifeld AG, Walsh T, Marshall D, Gress J, Steinberg SM, Hathorn J, Rubin M, Jarosinski P, Gill V, Young RC. J Clin Oncol; 1995 Jan 01; 13(1):165-76. PubMed ID: 7799016 [Abstract] [Full Text] [Related]